⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2026RSC PharmaceuticsOpen Access

Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma

Zeina Kassem Jenny K. W. Lam Hanieh Khalili

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to explore innovative designs of bispecific antibodies for asthma treatment via inhalation.
Focus on bispecific antibody design
Investigate inhalable biologics
Emphasize localized pulmonary delivery
Proposed bispecific antibodies demonstrate effective targeting for asthma
Local delivery shows potential for improved therapeutic outcomes
Inhalation method enhances treatment options for asthma management

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Advanced strategies enhance localized treatment of asthma through inhalable bispecific antibodies.

Abstract

Pulmonary delivery of inhalable bispecific antibodies for the localised treatment of asthma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kassem et al. (2026) studied this question.

synapsesocial.com/papers/6974610cbb9d90c67120ae44 https://doi.org/10.1039/d5pm00230c

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Current and Emerging Biologic Therapies for Severe AsthmaReview · 2026 · 7 citations
2Enhanced powder dispersion of dual-excipient spray-dried powder formulations of a monoclonal antibody and its fragment for local treatment of severe asthmaOriginal Research · 2023 · 11 citations
3Emerging targeted therapies in asthma: from upstream epithelial biology to novel biologic and small-molecule strategiesOriginal Research · 2026
4Precision medicine for severe asthma – Biological targeted therapy2024 · 18 citations
5Management of Asthma: Future DirectionsSystematic Review · 2026